(Q36528251)

14 August 2017

1 reference

title

AMP-activated protein kinase and the regulation of glucose transport (English)

1 reference

14 August 2017

2

Niels Jessen

1 reference

14 August 2017

Nobuharu Fujii

1

1 reference

PubMed ID

16822958

14 August 2017

Laurie J Goodyear

series ordinal

3

1 reference

14 August 2017

5 July 2006

1 reference

American Journal of Physiology - Endocrinology and Metabolism

14 August 2017

1 reference

14 August 2017

291

1 reference

14 August 2017

E867-77

1 reference

14 August 2017

5

1 reference

Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport

14 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Interactions of ATP, oestradiol, genistein and the anti-oestrogens, faslodex (ICI 182780) and tamoxifen, with the human erythrocyte glucose transporter, GLUT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 is independent of p38MAPK activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Acute exposure to AICAR increases glucose transport in mouse EDL and soleus muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Genistein directly inhibits GLUT4-mediated glucose uptake in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The AMP-activated protein kinase cascade--a unifying system for energy control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Role of Ca2+/calmodulin-dependent kinases in skeletal muscle plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Exercise, glucose transport, and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Passive stretching produces Akt- and MAPK-dependent augmentations of GLUT4 translocation and glucose uptake in skeletal muscles of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Contraction signaling to glucose transport in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Dealing with energy demand: the AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

GLUT4-containing vesicles are released from membranes by phospholipase D cleavage of a GPI anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The molecular basis of skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Expression profiling of the gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma3 in white skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Dissociation of 5' AMP-activated protein kinase activation and glucose uptake stimulation by mitochondrial uncoupling and hyperosmolar stress: differential sensitivities to intracellular Ca2+ and protein kinase C inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Adenosine 5'-monophosphate-activated protein kinase and p38 mitogen-activated protein kinase participate in the stimulation of glucose uptake by dinitrophenol in adult cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Long-term AICAR administration and exercise prevents diabetes in ZDF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

AMPK beta subunit targets metabolic stress sensing to glycogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Endofacial competitive inhibition of glucose transporter-4 intrinsic activity by the mitogen-activated protein kinase inhibitor SB203580.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Effects of calcineurin activation on insulin-, AICAR- and contraction-induced glucose transport in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Contraction regulation of Akt in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

IRS-1 regulation in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Mammalian AMP-activated protein kinase subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The regulation of AMP-activated protein kinase by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The blooming of the French lilac

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Stimulation of glucose transport by AMP-activated protein kinase via activation of p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Troglitazone induces GLUT4 translocation in L6 myotubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR--an activator of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00207.2006

10.1152/AJPENDO.00207.2006

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16822958